Browse 493 Dystrophy clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.
Muscular dystrophy is not one disease but a group of more than 30 inherited conditions that weaken muscles over time, each caused by a different gene. Some, like Duchenne, begin in early childhood, while the most common adult form, myotonic dystrophy, may not appear until middle age. Most forms still have no treatment that slows them, and knowing the exact gene now opens the door to trials of gene therapies and medicines designed for one specific form.
Evaluating Long-term Use of a Pediatric Robotic Exoskeleton (P.REX/Agilik) to Improve Gait in Children With Movement Disorders
for
Cerebral Palsy, Muscular Dystrophy, Spina Bifida,
Location: Bethesda MD
Sponsor: National Institutes of Health Clinical Center (CC)
Sex: All
Age: 3 - 17
Code: NCT05726591
Recruiting
A Study to Evaluate the Safety and Clinical Activity of Intramuscular Doses of BB-301 Administered to Subjects With Oculopharyngeal Muscular Dystrophy With Dysphagia
for
Oculopharyngeal Muscular Dystrophy
Location: New York NY
Sponsor: Benitec Biopharma, Inc.
Sex: All
Age: 0 - 65
Code: NCT06185673
Phase 1, Phase 2, Recruiting
Investigating Exercise in Myotonic Dystrophy Type 2 (DM2)
for
Myotonic Dystrophy 2
Location: Boston MA
Sponsor: Massachusetts General Hospital
Sex: All
Age: 18 - 70
Code: NCT06716931
Recruiting
Investigational Use of Neuromuscular Ultrasound
for
Muscular Dystrophy, Peripheral Neuropathy,
Location: Bethesda MD
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)
Sex: All
Age: 18 - 70+
Code: NCT05237973
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study About the Safety of a Single ASP2020 Eye Injection and if it Helps People With Vision Loss From Stargardt-type Eye Conditions
for
Stargardt Disease, Stargardt Macular Dystrophy,
Location: Cincinnati OH, Dallas TX, Phoenix AZ
Sponsor: Astellas Institute for Regenerative Medicine
Sex: All
Age: 6+
Code: NCT07734064
Phase 1, Recruiting
Brain Stimulation Effects on Orientation and Mobility Skills in Adults With Vision Impairment
for
Retinitis Pigmentosa (RP), Rod Cone Dystrophy,
Location: Waterloo
Sponsor: University of Waterloo
Sex: All
Age: 18+
Code: NCT07341763
Recruiting
Remote Assessments and Genetic Determinants of Congenital and Childhood Myotonic Dystrophy
for
Myotonic Dystrophy Type 1, Congenital DM1, Juvenile DM1,
Location: Rochester NY
Sponsor: University of Rochester
Sex: All
Age: 0 - 17
Code: NCT07630389
Recruiting
PBGENE-DMD Phase 1/2a Safety and Preliminary Efficacy Study in Duchenne Muscular Dystrophy (FUNCTION-DMD)
for
Duchenne Muscular Dystrophy With Mutations Amenable to PBGENE-DMD,
Location: St Louis MO, Little Rock AR
Sponsor: Precision BioSciences, Inc.
Sex: Male
Age: 2 - 7
Code: NCT07429240
Phase 1, Phase 2, Recruiting
Muscle Health Measurements Using Electrical Impedance Myography
A Phase 1/2 Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BMN 351 in Participants With Duchenne Muscular Dystrophy
for
Duchenne Muscular Dystrophy
Location: London
Sponsor: BioMarin Pharmaceutical
Sex: Male
Age: 4 - 10
Code: NCT06280209
Phase 1, Phase 2, Recruiting
Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Neuromuscular Disease
A Study to Learn How Stargardt-type Eye Conditions Progress in Children and Adults
for
Stargardt Disease, Stargardt Macular Dystrophy,
Location: Philadelphia PA, Durham NC, Miami FL, Pittsburgh PA,
Sponsor: Astellas Pharma Global Development, Inc.
Sex: All
Age: 6+
Code: NCT07425574
Recruiting
BetterLife FSHD: A Patient-driven Health and Research Platform
for
FSH, FSH Muscular Dystrophy,
Location: Randolph MA
Sponsor: FSHD Society
Sex: All
Age: 1+
Code: NCT07409142
Recruiting
A Gene Transfer Therapy Study to Evaluate the Safety of and Expression From Delandistrogene Moxeparvovec (SRP-9001) in Participants With Duchenne Muscular Dystrophy (DMD) - Non-Ambulatory Cohort
for
Duchenne Muscular Dystrophy
Location: Norfolk VA, Durham NC, Gainesville FL, Chicago IL,
Sponsor: Sarepta Therapeutics, Inc.
Sex: Male
Age: 2+
Code: NCT04626674
Phase 1, Recruiting
Randomized Stepped Wedge Study of Emapalumab in APECED Enteritis